Efficacy and Safety of ABT-494, a Selective JAK-1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
选择性JAK-1抑制剂ABT-494在对甲氨蝶呤反应不足的类风湿性关节炎患者中的IIb期研究中的疗效和安全性
期刊:Arthritis & Rheumatology
影响因子:10.9
doi:10.1002/art.39808
Genovese, Mark C; Smolen, Josef S; Weinblatt, Michael E; Burmester, Gerd R; Meerwein, Sebastian; Camp, Heidi S; Wang, Li; Othman, Ahmed A; Khan, Nasser; Pangan, Aileen L; Jungerwirth, Steven